These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4382645)

  • 1. Brain dopamine and the amphetamine-reserpine interaction.
    Randrup A; Jonas W
    J Pharm Pharmacol; 1967 Jul; 19(7):483-4. PubMed ID: 4382645
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs.
    Scheel-Krüger J
    Eur J Pharmacol; 1972 Apr; 18(1):63-73. PubMed ID: 5031275
    [No Abstract]   [Full Text] [Related]  

  • 3. Amphetamine induced stereotyped behaviour correlated with the accumulation of O-methylated dopamine.
    Jonas W; Scheel-Krüger J
    Arch Int Pharmacodyn Ther; 1969 Feb; 177(2):379-89. PubMed ID: 5807174
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of gamma-aminobutyric acid on brain normetanephrine.
    Yessaian NH; Arakelian LN
    J Neurochem; 1970 Dec; 17(12):1689-90. PubMed ID: 5492988
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.
    Scheel-Krüger J; Randrup A
    Life Sci; 1967 Jul; 6(13):1389-98. PubMed ID: 6035768
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of four amphetamines on brain biogenic amines and their metabolites.
    Leonard BE
    Biochem Pharmacol; 1972 May; 21(9):1289-97. PubMed ID: 5038674
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
    Carlsson A; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 Dec; 2(3):196-201. PubMed ID: 5590343
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic properties and mechanism of action of amfonelic acid.
    Aceto MD; Botton I; Martin R; Levitt M; Bentley HC; Speight PT
    Eur J Pharmacol; 1970; 10(3):344-54. PubMed ID: 4393073
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in monoamines of rat brain during postnatal ontogeny.
    Agrawal HC; Glisson SN; Himwich WA
    Biochim Biophys Acta; 1966 Dec; 130(2):511-3. PubMed ID: 5972858
    [No Abstract]   [Full Text] [Related]  

  • 10. Paper chromatographic identification of catecholamines.
    Laasberg LH; Shimosato S
    J Appl Physiol; 1966 Nov; 21(6):1929-34. PubMed ID: 5929329
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-O-methyldopa, a new precursor of dopamine.
    Bartholini G; Kuruma I; Pletscher A
    Nature; 1971 Apr; 230(5295):533-4. PubMed ID: 4927759
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of drugs on the behavioural and biochemical actions of intraventricular 6-hydroxydopamine.
    Taylor KM; Laverty R
    Eur J Pharmacol; 1972 Jan; 17(1):16-24. PubMed ID: 5016577
    [No Abstract]   [Full Text] [Related]  

  • 13. The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.
    Laverty R; Taylor KM
    Anal Biochem; 1968 Feb; 22(2):269-79. PubMed ID: 4868086
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    Weissman A; Koe BK
    Life Sci; 1965 May; 4(10):1037-48. PubMed ID: 5838507
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of (+-)-p-chloroamphetamine on the susceptiblity to seizures and on the monoamine level in brain and heart of mice and rats.
    Pfeifer AK; Galambos E
    J Pharm Pharmacol; 1967 Jun; 19(6):400-2. PubMed ID: 4382372
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
    Uretsky NJ; Seiden LS
    J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
    [No Abstract]   [Full Text] [Related]  

  • 18. Disulfiram and the drug-induced effects on motility.
    Maj J; Przegaliński E; Wielosz M
    J Pharm Pharmacol; 1968 Mar; 20(3):247-8. PubMed ID: 4385060
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
    Florin SM; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of amphetamine induced release of reserpine-resistant 3 H-noradrenaline and 3 H- -methylnoradrenaline.
    Lundborg P; Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1971; 30(5):339-47. PubMed ID: 5172272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.